Press Releases from GMO-Safety.eu (2 total)
Pharma plants: new challenges for biological safety
Around the world, efforts are increasing to use genetically modified plants as production systems for vaccines or drugs. A number of plantmade pharmaceuticals (PMPs) are already undergoing clinical tests. In Germany, plans for a field trial with genetically modified peas to prevent infectious diseases in pigs have provoked heavy discussion.
Novel feed: Peas to combat infectious diseases
http://www.gmo-safety.eu/en/news/536.docu.html
For biological safety, the cultivation of plants that produce pharmaceutical substances poses completely new challenges.…
Biosafety of genetically modified plants: GMO-Safety.eu information portal bring …
Does genetically modified maize have an impact on beneficial insects? How does genetically modified oilseed rape affect pollen-collecting bees? How can transgenic pollen and seeds be prevented from spreading in the environment? These are just some of the questions being investigated in biological safety research worldwide. Answers and research findings, which are otherwise usually made public only at scientific conferences and congresses, are accessible to the public at www.gmo-safety.eu.
The information…
